跳至主要内容
临床试验/EUCTR2006-000995-33-SI
EUCTR2006-000995-33-SI进行中(未招募)1 期

EuroNet-Paediatric Hodgkin’s Lymphoma Group:First international Inter-Group Study for classical Hodgkin’s Lymphoma in Children andAdolescents - EuroNet-PHL-C1

Martin Luther University of Halle/Wittenberg0 个研究点目标入组 2,102 人开始时间: 2011年10月17日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
2,102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • diagnosis of classic Hodgkin’s lymphoma
  • patient aged under 18 years at time of diagnosis
  • written informed consent of the patient and/or the patient’s parents or guardian according to national laws
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 8
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • pre-treatment of Hodgkin’s lymphoma differing from study protocol (except recommended pre-phase therapy of a large mediastinal tumour) • known hypersensitivity or contraindication to study drugs
  • diagnosis of lymphocyte predominant Hodgkin’s lymphoma
  • prior chemotherapy or radiotherapy

研究者

发起方
Martin Luther University of Halle/Wittenberg

相似试验

进行中(未招募)
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1The first line therapy for childhood nodular lymphocyte-predominant Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.
EUCTR2007-004092-19-CZMartin Luther University of Halle/Wittenberg250
进行中(未招募)
1 期
Evaluation of the therapy of Hodgkin’s Lymphoma in Children and Adolescents
EUCTR2007-004092-19-DEMartin Luther University of Halle/Wittenberg200
进行中(未招募)
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1The first line therapy for childhood nodular lymphocyte-predominant Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.
EUCTR2007-004092-19-ATMartin Luther University of Halle/Wittenberg250
进行中(未招募)
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor classical Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-C1
EUCTR2006-000995-33-SEMartin-Luther-University Halle-Wittenberg1,200
进行中(未招募)
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor classical Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-C1
EUCTR2006-000995-33-PLMartin-Luther-University Halle-Wittenberg1,200